This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Artery Disease (CAD)
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Postmarket surveillance in terms of the safety and efficacy of Sirolimus-eluting Coroflex ISAR Stent for the treatment of "real world" patients with de-novo and restenotic lesions after stand-alone angioplasty in coronary arteries

Provided treatments

  • Device: stenting with the Coroflex ISAR sirolimus-eluting stent

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02629575. The sponsor of the trial is B. Braun Melsungen AG and it is looking for 2877 volunteers for the current phase.
Official trial title:
Coroflex ISAR 2000 Postmarket Surveillance Non-Interventional Study